Matthias Lubnow Selected Research

Oxygenators

8/2022	Coagulation abnormalities in patients with COVID-19 on venovenous ECLS increased risk for technical complications and support times but had no impact on survival.
1/2021	Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study.
1/2015	Technical-Induced Hemolysis in Patients with Respiratory Failure Supported with Veno-Venous ECMO - Prevalence and Risk Factors.
11/2014	Analysis of thrombotic deposits in extracorporeal membrane oxygenators by multidetector computed tomography.
6/2014	D-dimers as an early marker for oxygenator exchange in extracorporeal membrane oxygenation.
7/2013	Visualization of thrombotic deposits in extracorporeal membrane oxygenation devices using multidetector computed tomography: a feasibility study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias Lubnow Research Topics

Disease

10	Thrombosis (Thrombus) 08/2022 - 12/2011
10	Shock 01/2022 - 03/2014
10	Hemorrhage 01/2021 - 04/2011
9	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 01/2009
6	Heart Failure 01/2019 - 06/2010
5	COVID-19 08/2022 - 01/2021
5	Critical Illness (Critically Ill) 01/2021 - 03/2014
5	Respiratory Insufficiency (Respiratory Failure) 02/2019 - 01/2009
4	Heart Arrest (Cardiac Arrest) 12/2021 - 11/2012
4	Cardiogenic Shock 12/2021 - 01/2017
4	Infections 02/2021 - 04/2011
4	Hemolysis 01/2020 - 01/2015
3	Pulmonary Embolism 12/2021 - 01/2020
3	Pneumonia (Pneumonitis) 01/2021 - 09/2009
3	Respiratory Acidosis 01/2019 - 01/2011
3	Hypoxia (Hypoxemia) 11/2016 - 01/2011
3	Left Ventricular Dysfunction 12/2012 - 10/2011
3	Lung Injury 09/2009 - 04/2009
2	Acidosis 01/2017 - 04/2009
2	Inflammation (Inflammations) 06/2014 - 07/2009
1	Multiple Organ Failure (MODS) 09/2022
1	Neoplasms (Cancer) 01/2022
1	Mucormycosis 01/2022
1	Viremia 02/2021
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 02/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Disease Progression 01/2021
1	Hypoalbuminemia 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Obesity 02/2019
1	Ischemia 01/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019
1	Renal Insufficiency (Renal Failure) 01/2019
1	Brain Ischemia (Cerebral Ischemia) 12/2017
1	Low Cardiac Output 01/2017
1	Frailty 11/2016
1	Acute Kidney Injury (Acute Renal Failure) 09/2015
1	Wounds and Injuries (Trauma) 01/2015
1	Multiple Trauma (Multiple Injuries) 01/2015
1	Out-of-Hospital Cardiac Arrest 11/2012
1	Myocardial Ischemia (Ischemic Heart Diseases) 11/2011
1	Cardiomyopathies (Cardiomyopathy) 11/2011

Drug/Important Bio-Agent (IBA)

5	Hemoglobins (Hemoglobin)IBA 01/2021 - 05/2014
4	Fibrinogen (Factor I)FDA Link 01/2021 - 04/2011
3	pro-brain natriuretic peptide (1-76)IBA 12/2012 - 06/2010
3	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2011 - 06/2010
3	AcidsIBA 09/2009 - 04/2009
2	CytokinesIBA 09/2022 - 09/2009
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2011
2	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 06/2014
2	Carbon DioxideIBA 11/2014 - 09/2010
2	Troponin T (Troponin T1)IBA 11/2011 - 06/2010
2	Hydrochloric Acid (Hydrogen Chloride)FDA Link 09/2009 - 07/2009
1	Interleukin-8 (Interleukin 8)IBA 09/2022
1	liposomal amphotericin B FDA Link 01/2022
1	isavuconazoleIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 11/2021
1	Immunoglobulin G (IgG)IBA 02/2021
1	Immunoglobulin A (IgA)IBA 02/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2021
1	SteroidsIBA 02/2021
1	Immunoglobulin M (IgM)IBA 02/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	beta-LactamsIBA 01/2021
1	argatroban (MPQA)FDA Link 01/2021
1	IodineIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2019
1	Antithrombin IIIIBA 01/2019
1	BilirubinIBA 01/2017
1	Biological ProductsIBA 11/2016
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Hemostatics (Antihemorrhagics)IBA 11/2014
1	Oxygen (Dioxygen)IBA 01/2012
1	CreatinineIBA 10/2011

Therapy/Procedure

33	Extracorporeal Membrane Oxygenation 01/2022 - 01/2009
8	Therapeutics 01/2022 - 04/2016
6	Oxygenators 08/2022 - 07/2013
6	Cardiopulmonary Resuscitation (CPR) 12/2021 - 11/2012
5	Extracorporeal Circulation 01/2022 - 12/2018
5	Cannula 01/2019 - 12/2011
4	Resuscitation 12/2021 - 03/2014
3	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 01/2015
3	Membrane Oxygenators (Membrane Oxygenator) 11/2014 - 04/2011
2	Length of Stay 08/2022 - 12/2018
2	Artificial Respiration (Mechanical Ventilation) 01/2020 - 11/2016
2	Mechanical Ventilators (Ventilator) 11/2016 - 11/2014
2	Patient Readmission 11/2011 - 10/2011
1	Organ Transplantation 01/2022
1	Critical Care (Surgical Intensive Care) 01/2022
1	Tracheotomy 01/2021
1	Tracheostomy 01/2021
1	Drug Therapy (Chemotherapy) 02/2019
1	Prostatectomy (Retropubic Prostatectomy) 02/2019
1	Indwelling Catheters (Indwelling Catheter) 01/2019
1	Salvage Therapy 01/2019
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2017
1	Erythrocyte Transfusion 01/2015
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2012
1	Conservative Treatment 01/2012